News
Welcome to our news page. Here, you can learn more about the latest events and ATMP in Flemingsberg.
50 years of life-changing therapies
On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. From nuclear catastrophe the foundations of bone marrow transplantation had emerged, and with it, [...]
OptiCell Solutions enters a research collaboration with Karolinska Institutet
With the goal of supporting academia, healthcare, and industry in developing the cell and gene therapies of the future, OptiCell Solutions established its operations in Flemingsberg last year. The company has now entered into [...]
Together for the Medicine of the Future – Karolinska ATMP Centre and ATMP Centre Uppsala strengthens collaboration in advanced therapies
A letter of intent has been signed between the Karolinska ATMP Center and the ATMP Center Uppsala to deepen collaboration in the field of advanced therapies (ATMP). The initiative was celebrated with a joint [...]
A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated
With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between [...]
ATMP Sweden – now also in Flemingsberg!
The ATMP Sweden association carries out dedicated work focused on national coordination and communication to accelerate the development, accessibility, and implementation of advanced therapies (ATMP). They now also have an office space at Novum Labs. From here, Henrik Simonsson, Communications and Operative Lead, can work on the association’s plans to take its operations to even more meaningful heights.
OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg
Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on Campus Flemingsberg. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.
